Genetic risk score (GRS), derived from multiple PCa risk-associated single nucleotide polymorphisms (SNPs) have been shown to improve prostate biopsy-based diagnoses over PSA alone. The gene discussed is KLK3; the disease is posterior cortical atrophy.